NDC 66621-0790-2 Anavip
Crotalidae Immune F(ab)2(equine)
NDC Package Code 66621-0790-2
The NDC Code 66621-0790-2 is assigned to a package of 1 vial in 1 carton > 10 ml in 1 vial (66621-0790-1) of Anavip, a plasma derivative labeled by Rare Disease Therapeutics, Inc. The product's dosage form is injection, powder, lyophilized, for solution and is administered via intravenous form.This product is billed for "EA" each discreet unit and contains an estimated amount of 1 billable units per package.
NDC Code Structure
- 66621 - Rare Disease Therapeutics, Inc
- 66621-0790 - Anavip
- 66621-0790-2 - 1 VIAL in 1 CARTON
- 66621-0790 - Anavip
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the disclaimer below.
NDC HCPCS Crosswalk
This crosswalk is intended to help the public understand which drug products (identified by NDCs) are assigned to which HCPCS billing codes.
NDC 66621-0790-2 HCPCS crosswalk information with package details and bill units information.
NDC Billing Code | HCPCS Code | HCPCS Code Desc. | Dosage | Package Size | Package Quantity | Billable Units | Billable Units / Pkg |
---|---|---|---|---|---|---|---|
66621079002 | J0841 | Inj crotalidae im f(ab')2 eq | 120 MG | 1 | 1 | 1 | 1 |
* Please review the disclaimer below.